Actively Recruiting
Translation and Validation of the French mPCOSQ (mPCOSQ-F).
Led by CHU de Reims · Updated on 2025-08-07
350
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome. The first stage of the study consisted in translating the questionnaire from English to French. Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.
CONDITIONS
Official Title
Translation and Validation of the French mPCOSQ (mPCOSQ-F).
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 to 45
- Fluent in french
- Having a diagnosis of PCOS according to the international recommendations published in 2023
- Willing to participate in the study
- Affiliated to the french social security system
You will not qualify if you...
- Diagnosis of adrenal hyperplasia, androgen-producing tumor, Cushing's syndrome, or thyroid disorder
- Pregnancy or breast-feeding
- Under legal protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Damien JOLLY
Reims, France
Actively Recruiting
Research Team
S
Sara BARRAUD
CONTACT
C
Camille TETU
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here